Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study. Lancet Oncol. 2014 Aug; 15(9):954-65.
View in:
PubMed
subject areas
Adult
Aged
Azetidines
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Indoles
Infusions, Intravenous
Male
Maximum Tolerated Dose
Melanoma
Middle Aged
Mutation
Neoplasm Invasiveness
Neoplasm Staging
Patient Selection
Piperidines
Prospective Studies
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Risk Assessment
Skin Neoplasms
Sulfonamides
Survival Rate
Treatment Outcome
authors with profiles
Thomas F. Gajewski